Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU)

    • Product Name O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU)
    • Alias TOTU
    • Einecs 852-972-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    679511

    Chemical Name O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate
    Abbreviation TOTU
    Molecular Formula C10H18BF4N5O3
    Molecular Weight 345.09 g/mol
    Appearance White to off-white crystalline powder
    Solubility Soluble in DMF, DMSO, and acetonitrile
    Cas Number 148893-10-1
    Usage Peptide coupling reagent
    Melting Point 148-150°C (decomposes)
    Storage Conditions Store at 2-8°C, protect from moisture
    Sensitivity Hygroscopic
    Purity Typically ≥98%
    Hazard Classification Irritant
    Inchikey VUSIHRBYZXAZCD-UHFFFAOYSA-M

    As an accredited O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, opaque plastic bottle labeled with "TOTU, 25g", molecular formula, CAS number, and hazard warnings, sealed with a screw cap.
    Shipping TOTU should be shipped in tightly sealed containers, protected from moisture, heat, and direct sunlight. It must be handled as a chemical reagent, following regulations for potentially harmful organic compounds. Use secondary containment and provide clear labeling. Transportation may require hazard labeling, depending on jurisdiction and shipping quantities.
    Storage O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU) should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from moisture and incompatible substances. Protect from light and sources of ignition. Store at room temperature or lower (typically 2–8°C). Handle under inert atmosphere if possible to prevent hydrolysis and degradation.
    Application of O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU)

    Applications of O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU) in Industrial Manufacturing

    As a specialized manufacturer, we supply O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU) to advanced industrial customers with a focus on efficient and reliable peptide coupling. Below, we detail the primary downstream application scenarios, each reflecting industry-adopted practices, regulatory expectations, applied formulation levels, and the integration of this coupling reagent in commercial manufacturing chains.

    1. Peptide Active Pharmaceutical Ingredient (API) Synthesis

    Pharmaceutical manufacturers rely on our product in step-growth peptide synthesis for the production of therapeutic peptides. The coupling reagent’s unique properties allow for the rapid formation of amide bonds under mild conditions with minimized side reactions, directly supporting strict quality assurance requirements for peptide APIs used in injectable formulations, biosimilars, and complex drug entities. Quality departments pay close attention to residual coupling agents, in-process controls, and analytical traceability throughout scale-up.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP General Chapter <797> and <823> for sterile compounding and radiopharmaceuticals
    • European Pharmacopoeia (Ph. Eur.) monographs for peptide APIs
    • FDA 21 CFR Part 211 for finished pharmaceuticals

    Typical usage ratio

    • 1.0 to 1.2 molar equivalents per carboxyl group; molar ratio adjusted depending on peptide length and sequence reactivity

    Downstream process integration

    • Added during the activation stage of protected amino acid assembly on resin or solution phase; typically dissolved in DMF or NMP directly before acylation

    Final product types

    • Bulk peptide APIs for injectable medications
    • Oral and parenteral peptide drug substances
    • Sterile-grade raw materials for subsequent lyophilization
    • Peptide intermediates for conjugated biotherapeutics

    2. Custom Peptide Synthesis Services (Research & Diagnostics)

    Contract research organizations, diagnostics kit formulators, and life science service labs employ this coupling agent in high-throughput synthesizers and automated peptide workstations. Its consistent yield and minimal epimerization risk allow for reliable delivery of peptide sequences with strict lot traceability, supporting workflows for epitope mapping, enzyme substrate design, and antigen production for immunodiagnostics development.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems for analytical and research applications
    • ISO 13485:2016 for medical device (diagnostic kit) manufacturing
    • OECD Principles of Good Laboratory Practice (GLP) for non-clinical studies
    • National Institutes of Health NIH Guidelines for recombinant or synthetic nucleic acids

    Typical usage ratio

    • 1.0 to 1.3 equivalents relative to the amino acid or peptide carboxyl group, with optimization for sequence complexity and scale (mg to gram)

    Downstream process integration

    • Integrated in automated or manual Fmoc/t-Boc solid-phase peptide synthesis cycles; charged into coupling vessels following deprotection steps

    Final product types

    • Custom oligopeptides for biomedical assays
    • Synthetic antigens for ELISA and immunochromatographic kits
    • Peptide controls for mass spectrometry calibration
    • Epitope libraries for vaccine candidate screening

    3. Cosmetic Peptide Ingredient Manufacturing

    Producers of cosmetic peptide actives for skin care employ this coupling reagent in commercial peptide synthesis to achieve stringent purity requirements and scalability for bioactive ingredient manufacturing. Cosmetic industry regulations demand control over trace residues, impurity profiles, and allergen screening, necessitating robust in-process documentation and formulated ingredient consistency across batches.

    Industry compliance standards

    • ISO 22716:2007 Guidelines on Good Manufacturing Practices for cosmetic products
    • INCI registration and ingredient labeling requirements (EU Cosmetic Regulation EC No 1223/2009)
    • Cosmetic Ingredient Review (CIR) assessment for safety
    • REACH Regulation (EC) No 1907/2006 pre-registration as applicable

    Typical usage ratio

    • 0.95 to 1.15 equivalents per peptide bond; fine-tuned according to specific sequence reactivity and cosmetic formulation needs

    Downstream process integration

    • Used in protected amino acid coupling stages during large-scale batch or semi-batch peptide assembly before downstream purification/lyophilization

    Final product types

    • Palmitoyl pentapeptide-4, acetyl hexapeptide derivatives
    • Anti-aging and brightening peptide active concentrates
    • Skin-firming and cell signaling peptide additives
    • Peptide solutions for further blending in emulsion, serum, or gel bases

    4. Veterinary Pharmaceutical Peptide Production

    Animal health pharmaceutical manufacturers adopt this material for the synthesis of bioactive peptide drugs, including reproductive hormones and anti-infective agents approved for veterinary applications. Regulatory frameworks for veterinary pharmaceuticals require controls on process reproducibility, documentation for batch release, and compliance with active residue limits in end-use formulations.

    Industry compliance standards

    • VICH GL40: Good Manufacturing Practice for Active Pharmaceutical Ingredients for Veterinary Medicinal Products
    • European Medicines Agency (EMA) Guidance for veterinary pharmaceuticals
    • USP Veterinary Pharmaceuticals monographs
    • FDA 21 CFR Part 514 for new animal drug applications

    Typical usage ratio

    • 1.0 to 1.25 equivalents per coupling step; adjusted based on sequence length and resin loading in the veterinary API synthesis process

    Downstream process integration

    • Introduced during resin-bound acylation cycles or solution phase direct coupling under nitrogen conditions for large-scale veterinary peptide API production

    Final product types

    • Gonadorelin, buserelin, and synthetic reproductive hormones
    • Antimicrobial peptide ingredients for veterinary injectable preparations
    • Peptide growth promoters for livestock
    • Veterinary drug intermediates for multistep synthesis

    5. Industrial Peptide/Amide Intermediate Synthesis

    Chemical manufacturers engaged in the synthesis of specialty peptide or amide intermediates for agrochemical or fine chemical applications utilize the coupling agent to ensure high-yield bond formation while minimizing by-product formation. These intermediates may serve as building blocks for crop protection products, polymer additives, or performance chemicals, requiring thorough process control and product specification conformity for downstream application in regulated sectors.

    Industry compliance standards

    • ISO 9001:2015 for manufacturing process documentation
    • REACH pre-registration and substance dossier (as applicable in the EU)
    • Food and Agriculture Organization (FAO) procurement standards for agro intermediates
    • Internal corporate quality protocols for specialty chemicals

    Typical usage ratio

    • 1.05 to 1.25 equivalents per activated substrate; ratio depends on batch size and target application purity thresholds

    Downstream process integration

    • Charged during stepwise acylation or amidation following activation and solvent exchange steps in pilot to kilo-scale reactors

    Final product types

    • Agrochemical peptide intermediates and precursors
    • Polyfunctional amide monomers for advanced polymerization
    • Functionalization adducts for electronics and coating applications
    • Specialty linkers for hybrid organic-inorganic systems
    Free Quote

    Competitive O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU) prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing TOTU: O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium Tetrafluoroborate

    The Real Experience Behind TOTU

    Manufacturing O-((Ethoxycarbonyl)cyanomethylenamino)-N,N,N',N'-tetramethyluronium tetrafluoroborate, or TOTU, comes with stories from the floor—days measuring purity by HPLC, precision in packaging, containers filled and shipped to chemists worldwide. This reagent stands among the favorites for peptide synthesis, asked for by researchers who value efficiency and clean reactions. Our team works late into the night sometimes to ensure every batch meets high standards, and each drum labeled with our batch number offers more than just a chemical—it's a promise that we've kept our hands directly on quality.

    From Bench to Batch: Why Chemists Turn to TOTU

    Peptide chemists face common headaches: incomplete couplings, excessive by-products, inconsistent yields. As a manufacturer, we hear about these often—failed syntheses mean wasted time and stalled progress. Our process uses rigorously defined raw materials, constant moisture control, and monitoring for trace impurities that can derail a sensitive synthesis. TOTU, with its strong guanidinium core and tetrafluoroborate counterion, handles peptide couplings with remarkable reliability, and delivers less side reactions than older methods. Researchers switching from traditional coupling agents, like HBTU or DCC, appreciate the smoother workflow and clearer product profiles on analysis.

    Specifications That Go Beyond the Catalog

    We prepare TOTU to meet high analytical standards. Every lot goes through NMR testing, HPLC purity checks, and moisture analysis right here in our facility. Each specification—whether it reads 98% or higher—stands behind real hands-on work in synthesis. Purity matters, especially in solid-phase peptide synthesis, because contaminants can accumulate in repeated cycles. Each drum, vial, or package comes sealed under inert gas, direct from our isolation room. The fine white powder may seem simple, but behind every gram lie hours spent monitoring stability, shelf life, and solubility in polar aprotic solvents.

    Smoother Couplings, Simpler Purifications

    TOTU brings practical advantages that show up on the workbench. In our own R&D trials, peptide couplings run with TOTU complete faster, leave fewer urea by-products, and demand less time on purification columns. Peptides with sterically hindered sequences, which might stall using older reagents, often show better yields with TOTU. Our customers, ranging from university labs to pharmaceutical plants, often call back to say purification takes less time, and they use smaller volumes of hazardous solvents. Each kilogram we ship means less waste generated when compared with carbodiimide reagents, which can release insoluble dicyclohexylurea.

    What Sets TOTU Apart in Their Toolbox

    Traditional uronium and carbodiimide coupling agents have carried synthetic chemistry for decades, yet every method brings its quirks. TOTU doesn’t form the same troublesome by-products as DCC, and doesn’t need long activation steps like some phosphonium salts. Its stability under ambient conditions creates peace of mind, especially for teams working with sensitive amino acids or for automated peptide synthesizers cycling through dozens of runs. In our own plant, staff appreciate handling TOTU—lower volatility, reduced dust formation, and less hazardous decomposition. Product handling means fewer production interruptions and a safer line.

    Applications: Where TOTU Finds Its Place

    In peptide research, every cycle counts. TOTU consistently earns room in peptide assembly when reproducibility matters. Our chemists use it for both solid-phase and solution-phase methods. Designing new therapeutic candidates, macrocyclic peptides, or even small-molecule libraries—TOTU supports activation across a range of amino acids, protecting groups, and solvents. Reactions occur cleanly in DMF, NMP, or DMSO, and our process development team continually explores ways to limit solvent loads and improve sustainability. Pharmaceutical scale-up groups benefit from the agent’s relative ease during scale transitions, from milligram to kilogram synthesis.

    Collaborating With Cutting-Edge Teams

    Some of the world’s most innovative peptide synthesis groups call us for direct feedback on their results. We’re not just shipping a product out the door—we join in troubleshooting, process improvement, and even designing new workflows that center on TOTU’s strengths. One lab reported cleaner crude yields in their head-to-tail cyclization sequences; another published improved protocols for assembling long, “difficult” peptide chains containing multiple arginine or proline residues. We listen, compare notes, and revise our own manufacturing methods when we see opportunities for higher reproducibility or easier downstream processing.

    Why Specifications Matter for TOTU Production

    TOTU has a story that starts from our storage tanks—anhydrous conditions, constant temperature regulation, and high-grade solvents feed each batch. During every production run, small changes in water content or unintended exposure can alter final activity. Once, a single valve leak introduced trace water into a reaction vessel, and we caught the problem during final QC by observing slightly increased hydrolysis in sample tests. That entire batch never left. This cautious approach saves our clients time lost in failed reactions—and reflects a manufacturer’s investment in long-term partnerships, not just immediate sales.

    Differentiating TOTU from Similar Reagents

    Compared with reagents like HBTU, HATU, or PyBOP, TOTU avoids the hexafluorophosphate salts that can raise environmental or regulatory questions in larger plants. The tetrafluoroborate counterion reduces risk during waste handling, often simplifying disposal and EHS management. We’ve seen how residues from some alternatives interfere with mass spectrometry detection—TOTU leaves fewer persistent contaminants on expensive analytical instruments. Organic chemists managing automation platforms appreciate how TOTU’s physical form—it flows evenly, resists clumping, and doesn’t cake in humid conditions—allows longer runs with less operator intervention.

    The Impact in Scale-Up and GMP Settings

    Process engineers know that a year’s worth of bench experiments can fall apart at the ton scale if a reagent behaves unpredictably. We talk regularly with teams scaling up API intermediates, asking pointed questions about TOTU’s reaction kinetics, residual solvents, and compatibility with controlled environments. Our plant runs simulation batches under different air and humidity conditions to validate the agent’s performance before signing off on GMP shipments. Peptide APIs command strict traceability; every single batch destined for GMP campaigns comes with isolatable analytical records, stability profiles, and containment history, more than just a COA slip.

    Sustainability: Care in Manufacturing and Downstream Use

    Chemical manufacturing involves real environmental accountability. For years, we improved our processes for TOTU, minimizing raw material excess and capturing volatile organics through closed-loop distillation. By selecting less hazardous counterions and tightening process controls, we reduce onsite hazards and cut down on energy use during drying and milling. As researchers themselves push toward “greener” synthetic protocols, our attention to production waste translates to fewer headaches on the user end—disposal, ambient storage, and accident response all grow simpler. Facility audits and customer interviews shape our upgrades, steering away from obsolete, less sustainable chemistries.

    Stories from Real Users

    In conversation with long-term partners, product reliability comes up more than marketing claims ever could. A group synthesizing peptide-drug conjugates reported improved batch consistency after switching from a carbodiimide-based system to TOTU. Another, working on constrained macrocycles, shared how TOTU’s sharp endpoint in coupling eliminated days of labor previously spent on column clean-up. Troubleshooting together means we learn more quickly—the next batch incorporates those lessons. Every kilogram of TOTU reflects not only material science, but also an ongoing dialogue with laboratories from North America to Asia.

    Minimizing Occupational Hazards

    TOTU’s physical properties support safer handling. As manufacturers, our team prefers its manageable particle size and lower volatile content. Less dust means less risk of inhalation, and routine handling corrections grew less frequent after switching to this formulation years ago. Storage protocols improved as we discovered that TOTU tolerates short-term temperature fluctuations without product degradation, unlike some traditional uronium salts which clump or decompose during transport. Real gains in operator safety come from small choices made at each production step.

    Role in Next-Generation Synthesis Automation

    Automating peptide synthesis demands chemically robust, physically consistent reagents. Instrument manufacturers consult us routinely; their automated liquid-handling platforms require powders that feed reliably from hopper to reaction vessel. TOTU’s stability and flow help reduce blockages and maintenance, extending the uptime of expensive peptide synthesizers. Our development team tailors each production lot not just for purity, but also for bulk density profiles, so that each shipment performs seamlessly in high-throughput settings. This partnership—manufacturer to instrument maker to end user—drives improvements across laboratory automation.

    Peptide Purity: More Than Just a Number

    Peptide medicines demand high purity, accurate sequencing, and low levels of side products. In our facility, we embrace this focus during every TOTU run. Analytical controls target more than just percent purity; we set detection limits for process-related impurities, search for residual organic solvents, and analyze for unreacted precursors that might co-elute with peptides on the HPLC. Every improvement we make in purification protocols translates as savings in the downstream process—less effort spent on secondary purifications, fewer rejected batches, quicker release of research-grade or clinical trial material.

    Logistical Support from a Manufacturer’s Perspective

    Shipping chemicals across borders and climates brings unique challenges. As producers and logistics coordinators, we conduct stress testing—TOTU remains free-flowing after exposure to temperature cycles that mirror both winter and summer transport. Packing lines use high-barrier materials, protecting the powder from oxygen and atmospheric water. Requests for urgent delivery receive real checklists, not canned stock replies; our own staff drive overnight to freight terminals to prevent delivery disruptions in critical research timelines.

    Accountability: Beyond the Certificate of Analysis

    Our own chemists sign off every batch, reviewing all analytical data before release. This human element—checking not just instrument printouts, but actual sample vials under light, or scent-testing for trace amines—anchors our quality system. Failures, rare as they may be, prompt internal reviews, and the results become part of the next production cycle. Our open-door policy encourages users to query data, request custom analytical runs, or request stability updates for specialized projects or long-term storage studies.

    Regulatory Trends and TOTU Adoption

    A shifting landscape in global regulations pressures manufacturers to certify product integrity, track every precursor, and secure traceable shipment trails. We take part in chemical stewardship initiatives, reducing reliance on problematic raw materials and updating product documentation as standards evolve. As some coupling agents draw scrutiny for persistent by-products or hazardous decomposition, TOTU’s record stands clear of many such restrictions, facilitating smooth importation to major markets. This proactive stance does not just protect us, but serves every researcher relying on uninterrupted supply chains.

    Ongoing Innovation: TOTU’s Role in Future Chemistry

    Peptide synthesis continues to advance, driven by demands for ever more complex molecules. We test modifications—alternate counterion options, eco-friendlier packaging, and new process auxiliaries—all while keeping the core chemistry consistent and trustworthy. Each improvement comes from actual plant data, not just theoretical gains. Whether developing new radio-labeled peptides for diagnostics, longer oligonucleotide-peptide hybrids, or next-generation peptide macrocycles, teams rely on TOTU’s performance and our promise as a manufacturer to support unbroken lines of supply.

    Listening to the Community

    All production happens with one eye on the feedback desk. Minor packaging changes—tighter lids, anti-tamper seals, inert gas purging—spring directly from user conversations. In internal meetings, it’s not uncommon for one of our chemists to pull out handwritten notes from a site visit or video call, suggesting process tweaks or documenting a recurring question. This loop—chemists, end users, production staff—keeps us competitive and honest in our manufacturing practice.

    Why Direct-from-Manufacturer Supply Makes a Difference

    Working as the actual producer enables tight control over every input and output. We verify solvent origins, test for trace metals, and select packaging lines to match the physical demands of long-term storage. Third-party repackers may promise availability, but our place at the start of the value chain ensures direct responsibility. When problems arise, investigations start with our own plant staff—no deferral, no delay. This model supports confidence for researchers who build experiments on exact batch-to-batch consistency.

    Conclusion: Crafting Quality for Better Science

    TOTU’s journey, from raw materials through final shipment, traces a path marked by human oversight, technical precision, and real-world adaptability. Our story, as the actual manufacturer, always centers on supporting chemists with products they can trust. Improvements in handling, purity, logistics, and sustainability follow not as abstract goals, but as real changes reflecting both the challenges and innovations of modern peptide synthesis. By keeping our hands on every step and ears open to feedback, we help push research one synthesis further, one peptide cleaner, one cycle faster.